Squamous Cell Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Squamous Cell Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer [Phase 2, Phase 3]
Phase 2/3 trial update evaluating JMT101 with docetaxel in squamous cell non-small cell lung cancer; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial SCT-I10A plus docetaxel versus placebo in previously treated squamous cell non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ） [Phase 3]
Phase 3 trial evaluating neoadjuvant sintilimab plus chemotherapy for resectable squamous cell non-small cell lung cancer is recruiting.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017) [Phase 3]
Phase 3 trial comparing nivolumab to docetaxel in previously treated advanced/metastatic squamous cell non-small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens [Phase 2]
Phase 2 trial of nivolumab in advanced or metastatic squamous cell non-small cell lung cancer after at least 2 prior regimens completed; res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.